SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-074569
Filing Date
2018-03-08
Accepted
2018-03-08 10:49:18
Documents
5
Effectiveness Date
2018-03-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d526660ds8.htm S-8 38109
2 EXHIBIT 5.1 d526660dex51.htm EX-5.1 11366
3 EXHIBIT 23.1 d526660dex231.htm EX-23.1 1347
4 GRAPHIC g526660g0305205304609.jpg GRAPHIC 1785
5 GRAPHIC g526660g74e14.jpg GRAPHIC 2987
  Complete submission text file 0001193125-18-074569.txt   58760
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-223514 | Film No.: 18675458
SIC: 2834 Pharmaceutical Preparations